Public Profile

Siempharma

Siempharma, officially known as Siempharma Pvt. Ltd., is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2004, the company has made significant strides in the development and distribution of high-quality generic and specialty pharmaceuticals, primarily focusing on therapeutic areas such as oncology, cardiology, and neurology. With a robust operational presence across various regions, Siempharma is committed to delivering innovative healthcare solutions. The company’s core offerings include a diverse range of formulations and active pharmaceutical ingredients (APIs), distinguished by their adherence to stringent quality standards and regulatory compliance. Siempharma's dedication to research and development has positioned it as a trusted name in the market, earning accolades for its contributions to affordable healthcare.

DitchCarbon Score

How does Siempharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

4

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Siempharma's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Siempharma's reported carbon emissions

Siempharma, headquartered in India, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Siempharma may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be essential for Siempharma to establish clear commitments and measurable targets to address its carbon footprint and contribute to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Siempharma's primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Siempharma is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Siempharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

SBTi
CDP
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in

Kiffle Kitchen LLC

US
Sugar Processing
Updated 8 days ago

Great Lakes Warehouse Corp.

US
Sugar Processing
Updated 12 days ago
CDP

Sage V Foods

US
Sugar Processing
Updated 5 days ago

Chemlock Nutrition

US
Sugar Processing
Updated 5 days ago

Grassland Beef

US
Sugar Processing
Updated 9 days ago

Keany Produce

US
Sugar Processing
Updated 12 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers